The top recreational drug is fentanyl. There are treatments that can combat it, but people must want to use them. Unfortunately, addicts often don't want to change. A new analysis of those who abuse opioids found that only 22 percent used buprenorphine for a year. Most dropped it after a month.
The authors say the cost of medication is a factor but that is in defiance of everything known about addictive behavior - it suggests a cheaper cost would solve the problem yet users find money for drugs. Spending $120 a month is not causing someone to go back to using fentanyl while spending $30 a month keeps them on a treatment program, such thinking infantalizes people and denies them any agency. Obamacare's preventive drug list, which would require no cost-sharing, won't help, it is just another subsidy for pharmaceutical companies and will cost taxpayers more. Since 78 percent won't take it at all, we're already going to be paying for the health care of 100,000, and more costs added on to the billions of dollars we're already forced to subsidize have little value.
Citation: Leech AA, McNeer E, Roberts AW, et al. Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder. JAMA Intern Med. Published online August 07, 2023. doi:10.1001/jamainternmed.2023.2826. The lead author of the Letter is a statistical reviewer for JAMA.
- Buprenorphine Is A Schedule III Drug For Opioid Addiction- Taking It Off Prescription Will Save Lives
- Opioid And Heroin Crisis Linked To Overprescribing Painkillers
- Pain Patients Are Not The Problem, Shows CDC, Opiod Deaths Are Due To Recreational Fentanyl Plus Benzos, Cocaine, And Meth
- FDA Approves Narcan Drug Overdose Medication For OTC Sale
- JAMA Links Doctor Payments To Opioid Prescriptions